These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 45569)

  • 1. Enkephalin-dopamine interactions in behavioral arousal.
    Katz RJ; Carroll BJ
    Prog Neuropsychopharmacol; 1979; 3(4):395-8. PubMed ID: 45569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [D-Ala2,NMePhe4,Gly-ol5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically inhibits behaviors induced by the dopamine D2 agonist RU 24213.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1991 Aug; 201(1):41-6. PubMed ID: 1686589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats.
    Megens AA; Cools AR
    Eur J Pharmacol; 1981 May; 71(2-3):247-58. PubMed ID: 6265235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mouse.
    Ukai M; Toyoshi T; Kameyama T
    Pharmacol Biochem Behav; 1993 Nov; 46(3):587-91. PubMed ID: 7904071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
    Jackson DM; Ross SB; Larsson LG
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral activation by enkephalins in mice.
    Katz RJ; Carroll BJ; Baldrighi G
    Pharmacol Biochem Behav; 1978 Apr; 8(4):493-6. PubMed ID: 674255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis.
    Agmo A; de Avila N
    Pharmacol Biochem Behav; 1985 Apr; 22(4):599-603. PubMed ID: 3991768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone.
    Biggio G; Casu M; Corda MG; Di Bello C; Gessa GL
    Science; 1978 May; 200(4341):552-4. PubMed ID: 205949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dopaminergic mechanisms in mediating the central behavioral effects of morphine in rodents.
    Feigenbaum J; Yanai J
    Neuropsychobiology; 1984; 11(2):98-105. PubMed ID: 6090975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL; Rothman RB; Westfall TC
    Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice.
    Vetulani J; Sansone M; Oliverio A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):967-71. PubMed ID: 6891071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
    Extein I; Lo C; Goodwin FK; Schoenfeld RI
    Psychiatry Res; 1979 Dec; 1(3):333-9. PubMed ID: 233159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of behavioral responses by [D-Ala2, NMePhe4, Gly-ol]enkephalin, [D-Ala2] deltorphin II and [D-Pen2, L-Pen5]enkephalin in the mouse.
    Ukai M; Toyoshi T; Mizutani M; Sasaki Y; Kameyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):161-8. PubMed ID: 7941781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC; Houwing HA; Horn AS
    Eur J Pharmacol; 1982 Jun; 81(1):75-87. PubMed ID: 6126370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.